Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_418
Snippet: Survey data indicated 85.1% of respondents initiate glucocorticoid treatment at 2 mg/kg/d. 80.5% begin to taper glucocorticoids at ≥2 weeks, with each additional step at 2-4 week intervals (97%). 85.4% of respondents decrease by 25% of the original dose at each step, with 79% of responses indicating glucocorticoid treatment for greater than three months. Estimated relapse rates within six months of discontinuing immunosuppressive therapy was < .....
Document: Survey data indicated 85.1% of respondents initiate glucocorticoid treatment at 2 mg/kg/d. 80.5% begin to taper glucocorticoids at ≥2 weeks, with each additional step at 2-4 week intervals (97%). 85.4% of respondents decrease by 25% of the original dose at each step, with 79% of responses indicating glucocorticoid treatment for greater than three months. Estimated relapse rates within six months of discontinuing immunosuppressive therapy was < 20% (85.7% of respondents).
Search related documents:
Co phrase search for related documents- glucocorticoid treatment and original dose: 1
- glucocorticoid treatment and step original dose: 1
- immunosuppressive therapy and original dose: 1
- immunosuppressive therapy and relapse rate: 1
- immunosuppressive therapy and step original dose: 1
- original dose and step original dose: 1
Co phrase search for related documents, hyperlinks ordered by date